Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1059 of 5804
-
New injection aims to save Insulin-Making cells in type 1 diabetes
Disease control Recruiting nowThis study will examine the safety of three times weekly SC injections of OPT101 at each of three dose levels over two weeks as well as one year of treatment with SC OPT101 or placebo to match at a single dose level.
Phase: PHASE2 • Sponsor: Op-T LLC • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Can a medical glue stop repeat brain bleeds? new study seeks answers.
Disease control Recruiting nowThe aim of the study is to proof the effectiveness of Histoacryl® on preventing recurrence or progression of subdural hematoma after embolization of the middle meningeal artery.
Sponsor: Aesculap AG • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
New diabetes shot aims to help when pills or insulin fall short
Disease control Not yet recruitingThis study will be conducted to evaluate the efficacy and safety of GZR101-80 Injection in patients with type 2 diabetes mellitus inadequately controlled on oral antidiabetic drugs or Basal Insulin.
Phase: PHASE2 • Sponsor: Gan & Lee Pharmaceuticals. • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Can early gene testing unlock better cancer treatments?
Knowledge-focused Not yet recruitingThe European Society for Medical Oncology (ESMO) strongly recommends to develop multigene sequencing in the framework of molecular screening programmes, in order to improve access to innovative drugs and to accelerate clinical research in cancers. * Accordingly, this project aim…
Phase: NA • Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC
-
Enzyme pills could help severe pancreatitis patients regain weight
Disease control Recruiting nowIn this multicenter, double blinded, placebo-controlled, 1:1 parallel group RCT, the investigators propose to evaluate the impact of pancreatic exocrine replacement therapy on patients with acute necrotizing pancreatitis (ANP). The investigators will include patients of 18-60yrs …
Phase: PHASE3 • Sponsor: Asian Institute of Gastroenterology, India • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Tetris tested as a tool to block traumatic flashbacks
Symptom relief Not yet recruitingPost-Traumatic Stress Disorder (PTSD) is characterized by recurrent, intrusive memories of traumatic events that cause significant distress and functional impairment. Although trauma-focused treatments are effective, they typically require deliberate recollection of traumatic exp…
Phase: NA • Sponsor: Shaanxi Normal University • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC
-
Single-Session laser combo could simplify prostate cancer care
Disease control Not yet recruitingThis prospective study aims to validate the clinical outcomes of performing a concomitant trans-perineal prostate biopsy and laser ablation (termed "Bioblation") during a single session. The intervention is designed for symptomatic patients presenting with lower urinary tract sym…
Phase: NA • Sponsor: Benha University • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Could stem cells ease stiff spine? new trial begins
Disease control Not yet recruitingThe goal of this clinical trial is to evaluate the safety, tolerability and efficacy of human umbilical cord mesenchymal stem cell injection (HS\_SW01 cells injection) in patients with Ankylosing Spondylitis. Participants will be required to sign the informed consent form and wi…
Phase: PHASE1, PHASE2 • Sponsor: Shenzhen Huishan Biotechnology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
New drug combo aims to tackle lung cancer brain spread
Disease control Recruiting nowThe researchers are doing this study to test the safety of ivonescimab given in combination with standard chemotherapy and stereotactic radiosurgery (SRS) in people with non-small cell lung cancer (NSCLC) that has spread to the brain (brain metastases). The researchers will test …
Phase: PHASE1, PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Could a balloon replace stents for major heart artery clogs?
Disease control Not yet recruitingTrial name Intravascular Ultrasound- and Angiography-Derived Fractional Flow Reserve-Guided Drug-Coated Balloon for Large Coronary Artery De Novo Lesions Objectives To compare the safety and efficacy of Drug-Coated Balloons (DCB) versus Drug-Eluting Stents (DES) in large de novo …
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New cocktail aims to shrink untreatable liver tumors
Disease control Not yet recruitinghis is a single-arm, phase II clinical study evaluating the efficacy and safety of low-dose bevacizumab (7.5 mg/kg, Q3W) plus adebrelimab (1200 mg, Q3W) combined with transarterial chemoembolization (TACE) followed by hepatic arterial infusion chemotherapy (HAIC) with the FOLFOX …
Phase: PHASE2 • Sponsor: Third Affiliated Hospital, Sun Yat-Sen University • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Could your own gut fluid prevent Post-Surgery bowel chaos?
Disease control Recruiting nowThe goal of this clinical trial is to learn if antegrade intestinal fluid reinfusion works to prevent low anterior resection syndrome (LARS) in patients with prophylactic ileal stoma. The main questions it aims to answer are: 1. Does it work to prevent LARS by antegrade intestin…
Phase: PHASE2, PHASE3 • Sponsor: Pei-Rong Ding • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Stem cells aim to calm the immune attack in scleroderma
Disease control Not yet recruitingThe goal of this clinical trial is to evaluate the safety and tolerability of human umbilical cord mesenchymal stem cell injection(HS\_SW01 Cells injection) in patients with systemic sclerosis, and to further explore its pharmacokinetics(PK), immunological profile and preliminary…
Phase: PHASE1, PHASE2 • Sponsor: Shenzhen Huishan Biotechnology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Could a common stroke drug help people with a rare brain disease?
Symptom relief Not yet recruitingThe present study aims to conduct a randomized controlled trial to evaluate the efficacy and safety of 3-n-Butylphthalide (NBP) in improving symptoms in patients with Multiple System Atrophy (MSA). The main questions it aims to answer are: 1. To evaluate whether NBP soft capsule…
Phase: PHASE2, PHASE3 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC
-
New hope for advanced cancer: experimental drug HDM2024 enters human testing
Disease control Recruiting nowThe goal of this clinical trial is to learn if the study drug can work in advanced cancer patients. The main questions it aims to answer are: * Is the drug safe and tolerable ? * Does the drug exhibit antitumor activity ? Participants will receive the study drug once every thre…
Phase: PHASE1 • Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Breathing technique may enhance lymphedema therapy in breast cancer survivors
Symptom relief OngoingLymphedema is a persistent and chronic swelling condition that commonly develops after breast cancer surgeries involving axillary lymph node dissection (ALND). This condition causes pain, heaviness, and swelling in the upper limb, which severely limits shoulder mobility and funct…
Phase: NA • Sponsor: University of Lahore • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Rapid molecular tests could help doctors prescribe antibiotics more precisely
Disease control Recruiting nowThe goal of this clinical trial is to learn whether integrating rapid multiplex molecular microbiology results with predefined clinical and laboratory criteria into an antimicrobial stewardship program improves antimicrobial use in hospitalized adults receiving empiric high-impac…
Phase: NA • Sponsor: Maria Espinosa Perez • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New scan could help decide who benefits from heart surgery
Knowledge-focused Recruiting nowIschemic heart failure (IHF) is the final stage of coronary heart disease. Coronary revascularization is an important treatment method for IHF, but it has high perioperative risks and not all patients can benefit from it. Evaluation of viable myocardium is one of the important de…
Sponsor: Beijing Chao Yang Hospital • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
New antibody aims to supercharge immune system against cancer
Disease control Recruiting nowThe STARLYS trial is an adaptive, modular, Phase 1, open-label, multi-part, clinical trial evaluating MST-0312 in selected solid tumors. MST-0312 is a targeted bispecific antibody that is designed to locally stimulate the lymphotoxin beta receptor (LTBR) in order to boost the bod…
Phase: PHASE1 • Sponsor: Mestag Therapeutics Limited • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Can watching or hearing your muscles help you walk again after a stroke?
Disease control OngoingStroke commonly results in impairments of balance, mobility, and lower extremity motor function that limit independence in daily activities. Electromyography (EMG) biofeedback enhances motor relearning by providing real-time feedback regarding muscle activation. Although both vis…
Phase: NA • Sponsor: University of Lahore • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC